CD73 as a novel prognostic biomarker for human colorectal cancer

Journal of Surgical Oncology

Volumn 106, Issue 7, 2012, Pages 918-919

  Liu, Nan ^a   Fang, Xue Dong ^a   Vadis, Quo ^b  

^a JILIN UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; TUMOR MARKER;

ANTIGEN EXPRESSION; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; WESTERN BLOTTING;

5'-NUCLEOTIDASE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; TUMOR MARKERS, BIOLOGICAL;

EID: 84868360790     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23159     Document Type: Letter

References (10)

1. Wu XR, He XS, Chen YF, et al.: High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. J Surg Oncol 2012; DOI: 10.1002/jso.23056 [Epub ahead of print].
2. Zhang B:, CD73: A novel target for cancer immunotherapy. Cancer Res 2010; 70: 6407-6411.
3. Resta R, Thompson LF:, T cell signalling through CD73. Cell Signal 1997; 9: 131-139.
4. Eroglu A, Canbolat O, Demirci S, et al.: Activities of adenosine deaminase and 50-nucleotidase in cancerous and noncancerous human colorectal tissues. Med Oncol 2000; 17: 319-324.
5. Kondo T, Nakazawa T, Murata SI, et al.: Expression of CD73 and its ecto-50-nucleotidase activity are elevated in papillary thyroid carcinomas. Histopathology 2006; 48: 612-614.
6. Jin D, Fan J, Wang L, et al.: CD73 on tumor cells impairs antitumor T-cell responses: A novel mechanism of tumor-induced immune suppression. Cancer Res 2010; 70: 2245-2255.
7. Beavis PA, Stagg J, Darcy PK, et al.: CD73: A potent suppressor of antitumor immune responses. Trends Immunol 2012; DOI: 10.1016/j.bbr.2011.03.031 [Epub ahead of print].
8. Yamashita Y, Hooker SW, Jiang H, et al.: CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur J Immunol 1998; 28: 2981-2990.
9. Stagg J, Smyth MJ:, Extracellular adenosine triphosphate and adenosine in cancer. Oncogene. 2010; 29: 5346-5358.
10. Serra S, Horenstein AL, Vaisitti T, et al.: CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. Blood 2011; 118: 6141-6152.